Validation of the AJCC 8th Edition Staging System for Disseminated Appendiceal Cancer Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-institutional Analysis

[1]  S. Maithel,et al.  Do Lymph Node Metastases Matter in Appendiceal Cancer with Peritoneal Carcinomatosis? A US HIPEC Collaborative Study , 2022, Journal of Gastrointestinal Surgery.

[2]  M. Deraco,et al.  Comparative study of mucinous and non-mucinous appendiceal neoplasms with peritoneal dissemination treated by cyoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[3]  T. Pawlik,et al.  Outcomes of neoadjuvant chemotherapy before CRS‐HIPEC for patients with appendiceal cancer , 2020, Journal of surgical oncology.

[4]  Andrew J. Lee,et al.  Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. , 2020, American journal of surgery.

[5]  Andrew J. Lee,et al.  Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative , 2019, Journal of Gastrointestinal Surgery.

[6]  M. Ray,et al.  Analysis of Clinical Outcomes of Pseudomyxoma Peritonei from Appendicular Origin Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy-A Retrospective Study from INDEPSO , 2019, Indian Journal of Surgical Oncology.

[7]  M. Overman,et al.  Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient Selection , 2017, Annals of Surgical Oncology.

[8]  C. Compton,et al.  The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging , 2017, CA: a cancer journal for clinicians.

[9]  H. Zhang,et al.  The Management and Prognostic Prediction of Adenocarcinoma of Appendix , 2016, Scientific Reports.

[10]  C. Compton,et al.  The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base , 2016, Cancer.

[11]  E. Levine,et al.  Peritoneal Surface Disease (PSD) from Appendiceal Cancer Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Overview of 481 Cases , 2014, Annals of Surgical Oncology.

[12]  N. Aydin,et al.  Predictive and Prognostic Survival Factors in Peritoneal Carcinomatosis from Appendiceal Cancer After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy , 2014, Annals of Surgical Oncology.

[13]  J. Davison,et al.  Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade , 2014, Modern Pathology.

[14]  D. Elias,et al.  Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[15]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[16]  S. Andreola,et al.  Pseudomyxoma Peritonei: Clinical Pathological and Biological Prognostic Factors in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) , 2008, Annals of Surgical Oncology.

[17]  K. Geisinger,et al.  Pseudomyxoma Peritonei of Appendiceal Origin: A Clinicopathologic Analysis of 101 Patients Uniformly Treated at a Single Institution, With Literature Review , 2006, The American journal of surgical pathology.

[18]  R. Yantiss,et al.  Appendiceal Mucinous Neoplasms: A Clinicopathologic Analysis of 107 Cases , 2003, The American journal of surgical pathology.

[19]  K. Geisinger,et al.  Gelatinous Ascites: A Cytohistologic Study of Pseudomyxoma Peritonei in 67 Patients , 2001, Modern Pathology.

[20]  C. Nieroda,et al.  Prognostic Significance of Lymph Node Metastases in Patients with High-Grade Appendiceal Cancer , 2011, Annals of Surgical Oncology.

[21]  J. Cooper.  Ajcc Cancer Staging Manual , 1997 .